PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB · NASDAQ

Analytical Laboratory Instrument Manufacturing

Pacific Biosciences of California, Inc. is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.

Market Data

Price $1.37 -0.02 (-1.44%)

Market Cap$426M

P/E Ratio—

EPS$—

52W High$2.73

52W Low$0.85

Beta2.43

Data from Finnhub · Updated Mar 11, 2026